NO147301B - INTERMEDIATE IN THE PREPARATION OF 1-ISOPROPYLAMINE-3- (P-2 (2-METOXYETHYL) PHENOXY) -2-PROPANOL - Google Patents
INTERMEDIATE IN THE PREPARATION OF 1-ISOPROPYLAMINE-3- (P-2 (2-METOXYETHYL) PHENOXY) -2-PROPANOL Download PDFInfo
- Publication number
- NO147301B NO147301B NO810810A NO810810A NO147301B NO 147301 B NO147301 B NO 147301B NO 810810 A NO810810 A NO 810810A NO 810810 A NO810810 A NO 810810A NO 147301 B NO147301 B NO 147301B
- Authority
- NO
- Norway
- Prior art keywords
- isopropylamine
- propanol
- phenoxy
- preparation
- compound
- Prior art date
Links
- KFZMGEQAYNKOFK-UHFFFAOYSA-N 2-propanol Substances CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 title claims description 11
- 238000002360 preparation method Methods 0.000 title description 5
- KHUXNRRPPZOJPT-UHFFFAOYSA-N phenoxy radical Chemical class O=C1C=C[CH]C=C1 KHUXNRRPPZOJPT-UHFFFAOYSA-N 0.000 title 1
- 239000013067 intermediate product Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical group [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 229940095064 tartrate Drugs 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 1
- JJAKDWRVLCNKRN-UHFFFAOYSA-N 4-(1,1-diethoxy-2-methoxyethyl)phenol Chemical compound CCOC(COC)(OCC)C1=CC=C(O)C=C1 JJAKDWRVLCNKRN-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- AKPUJVVHYUHGKY-UHFFFAOYSA-N hydron;propan-2-ol;chloride Chemical compound Cl.CC(C)O AKPUJVVHYUHGKY-UHFFFAOYSA-N 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Foreliggende oppfinnelse angår et mellomprodukt med formelen The present invention relates to an intermediate product with the formula
som direkte kan anvendes som utgangsmateriale for fremstilling av terapeutisk aktiv 1-(isopropylamin)-3~fp-(2-metoksyetyl) fenoksyj-2-propanol med formelen: which can be directly used as starting material for the production of therapeutically active 1-(isopropylamine)-3~fp-(2-methoxyethyl)phenoxyj-2-propanol with the formula:
Den sistnevnte forbindelse som kan oppnås ved hydrering av det ovenfor nevnte nye utgangsmateriale er kjent for sine terapeutiske egenskaper og anvendes i terapi mot angina pectoris og forstyrrelser av hjerterytmen. The latter compound which can be obtained by hydration of the above-mentioned new starting material is known for its therapeutic properties and is used in therapy against angina pectoris and disturbances of the heart rhythm.
Fra forbindelsen V kommer man til sluttproduktet I, f.eks. ved hjelp av katalytisk hydrering. En egnet katalysa-tor er palladium, hvorved bæreren kan være f.eks. aktivkull, aluminiumoksyd, bariumsulfat. Som oppløsningsmiddel kan anvendes lavere alkoholer, til hvilket det eventuelt er tilsatt mineralsyrer, iseddik eller blandinger derav. Alt etter opp-løsningsmidlet er den hensiktsmessige temperatur mellom romtemperatur og 80°C ogtrykket mellom 1 og 5 atmosfærer. Ved valget av oppøsningsmidlet, temperaturen, trykket samt katalysatoren og mengden derav ledes reaksjonen slik at hydroksygruppen i forbindelse V hydreres til en mety le.ngruppe . From the compound V you get to the final product I, e.g. by means of catalytic hydrogenation. A suitable catalyst is palladium, whereby the carrier can be e.g. activated carbon, aluminum oxide, barium sulfate. As a solvent, lower alcohols can be used, to which mineral acids, glacial acetic acid or mixtures thereof have optionally been added. Depending on the solvent, the appropriate temperature is between room temperature and 80°C and the pressure between 1 and 5 atmospheres. By choosing the dissolving agent, the temperature, the pressure as well as the catalyst and the amount thereof, the reaction is directed so that the hydroxy group in compound V is hydrogenated to a methylene group.
Fremstillingen av nevnte forbindelse er tidligere beskrevet, blant annet i NO-PS 132798.'I denne fremgangsmåte kreves det i fremstillingen av utgangsstoffet flere trinn, og en del av disse trinn har dårlig utbytte. The preparation of said compound has previously been described, among other things in NO-PS 132798. In this method, several steps are required in the preparation of the starting material, and some of these steps have a poor yield.
Utgangsmaterialet for fremstilling av forbindelsen V oppnås ,fra p-(1,l-dietoksy-2-ketoksyetyl)fenol eller et annet ketalderivet ifølge i litteraturen angitte fremgangsmåter,, The starting material for the preparation of compound V is obtained from p-(1,1-diethoxy-2-ketoxyethyl)phenol or another ketal derivative according to methods specified in the literature.
Man lar ketalderivatet: reagere med epiklorhydrin, hvorved det oppnås en forbindelse med formelen: The ketal derivative: is allowed to react with epichlorohydrin, whereby a compound with the formula is obtained:
Forbindelsen III amineres i isopropylamin, hvoretter ketalet nedbrytes i sur vannoppløsning, hvorved det oppnås en forbindelse med følgende formel: The compound III is aminated in isopropylamine, after which the ketal is decomposed in acidic water solution, whereby a compound with the following formula is obtained:
Fra forbindelsen II kommer man frem til forbindelsen IV uten rensning av mellomproduktene, hvorved fremstillingen kan utføres som en kontinuerlig prosess. From compound II one arrives at compound IV without purification of the intermediate products, whereby the preparation can be carried out as a continuous process.
Heretter underkastes forbindelsen IV en katalytisk hydroring som fører til oppnåelse av den tilsvarende hydroksy-forbindel^e med formelen: The compound IV is then subjected to a catalytic hydrogenation which leads to obtaining the corresponding hydroxy compound with the formula:
Følgende eksempler skal illustrere oppfinnelsen nærmere uten å innskrenke beskyttelsesomfanget Eks empel 1 The following examples shall illustrate the invention in more detail without limiting the scope of protection Example 1
l-isop ropylamin-5-[ p-(2- metoksy-l-ok syet yl) fenoksyj - 2- propanol 1-isopropylamine-5-[p-(2-methoxy-1-oxyethyl)phenoxy-2-propanol
Man fremstiller en natriummetanolatoppløsning med A sodium methanolate solution is prepared with
'4,4 g natrium og 270 ml etanol. Til den oppnådde oppløsning tilsettes ved romtemperatur 37,7 g p-(1,l-dietoksy-2-metoksyetyl)fenol. Man tilsetter 55 ml epiklorhydrin og blander ved romtemperatur i 1 døgn. Deretter dampes det hele inn. '4.4 g of sodium and 270 ml of ethanol. To the solution obtained, 37.7 g of p-(1,1-diethoxy-2-methoxyethyl)phenol are added at room temperature. 55 ml of epichlorohydrin is added and mixed at room temperature for 1 day. The whole thing is then steamed in.
Resten opptas i kloroform og vaskes med vann. Deretter følger tørking med natriumsulfat og inndamping. Inndampingsresten oppløses i 300 ml isopropylamin, og oppløsningen kokes under tilbakeløp i 1 døgn og deretter dampes det hele inn igjen. Inndampingsresten oppløses i vann, og oppløsningens pH juster-es til 1 ved hjelp av saltsyre. Por fullstendig nedbryting av ketalet, blandes det 1 time ved romtemperatur. Deretter følger en vaskeekstraksjon med etylacetat. Vannfasen gjøres basisk med konsentrert ammoniakk, og produktet ekstraheres med etylacetat. Ekstraktene behandles med aktivkull, tørkes og dampes inn. Produktet krystalliseres som hydroklorid ved opp-løsning i HCl-isopropanol og utfelling med etylacetat. Det oppnådde hydroklorid har et smeltepunkt på 125-126°C. The residue is taken up in chloroform and washed with water. This is followed by drying with sodium sulphate and evaporation. The evaporation residue is dissolved in 300 ml of isopropylamine, and the solution is boiled under reflux for 1 day and then the whole is evaporated again. The evaporation residue is dissolved in water, and the pH of the solution is adjusted to 1 using hydrochloric acid. For complete decomposition of the ketal, it is mixed for 1 hour at room temperature. This is followed by a washing extraction with ethyl acetate. The water phase is made basic with concentrated ammonia, and the product is extracted with ethyl acetate. The extracts are treated with activated carbon, dried and evaporated. The product is crystallized as hydrochloride by dissolution in HCl-isopropanol and precipitation with ethyl acetate. The resulting hydrochloride has a melting point of 125-126°C.
Således oppnådd 10 g l-isopropylamin-3-/p-(2-metoksy-1-oksoetyl)-fenoksyj-2-propanolhydroklorid oppløses i 150 ml eddiksyre. Deretter tilsettes 1,5 g 10%-ig palladiumkull, og man gjennomfører en hydrering ved 30-40°C og normaltrykk inntil en ekvivalent hydrogen er forbrukt. Deretter filtreres katalysatoren av, og oppløsningsmidlet avdampes. Resten oppløses i vann, og oppløsningen gjøres alkalisk med lut. Produktet oppløses i kloroform. Kloroformen dampes :.av. Tartratet frem-stilles av produktet i vinsurt aceton. Det oppnådde tartrat har i krystallisert form et smeltepunkt på ca. 120°C. The thus obtained 10 g of 1-isopropylamine-3-(p-(2-methoxy-1-oxoethyl)-phenoxy-2-propanol hydrochloride) is dissolved in 150 ml of acetic acid. Then 1.5 g of 10% palladium charcoal is added, and a hydration is carried out at 30-40°C and normal pressure until an equivalent of hydrogen has been consumed. The catalyst is then filtered off, and the solvent is evaporated. The remainder is dissolved in water, and the solution is made alkaline with lye. The product is dissolved in chloroform. The chloroform is evaporated :.off. The tartrate is produced from the product in tartaric acetone. In crystallized form, the obtained tartrate has a melting point of approx. 120°C.
Eksemp el 2 Example or 2
1- isoprop ylamin- 3- l.p- ( 2- meto ksyetyl) fenoksy. y - 2- pro-panol 10 g 1-isopropylamin-3-fp-(2-metoksy-l-hydroksyetyl)fo-noksy./2-propanolhydroklorid oppløses i 150 ml iseddik, det tilsettes 1,8 g 10%- ig Pd/BaSO^, og det hele hydreres ved 35 C inntil en andre ekvivalent hydrogen er forbrukt. Deretter'følger avfiltrering av katalysatoren og inndamping. Resten oppløses i vann, og oppløsningen gjøres alkalisk med luft. 1-isopropylamine-3-l.p-(2-methoxyethyl)phenoxy. y - 2-propanol 10 g of 1-isopropylamine-3-fp-(2-methoxy-1-hydroxyethyl)phonoxy./2-propanol hydrochloride is dissolved in 150 ml of glacial acetic acid, 1.8 g of 10% Pd/BaSO^, and the whole is hydrogenated at 35 C until a second equivalent of hydrogen is consumed. The catalyst is then filtered off and evaporated. The remainder is dissolved in water, and the solution is made alkaline with air.
Produktet ekstraheres i kloroform. Kloroformen dampes av. Produktet overføres til tartrat i vinsurt aceton. Det oppnådde tartrat har et smeltepunkt på ca. 120°C. The product is extracted in chloroform. The chloroform is evaporated. The product is transferred to tartrate in tartaric acetone. The obtained tartrate has a melting point of approx. 120°C.
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI762507A FI55649C (en) | 1976-09-01 | 1976-09-01 | NYTT FOERFARANDE FOER FRAMSTAELLNING AV 1-ISOPROPYLAMINE-3- (P- (2-METHOXYETHYL) PHENOXY) -2-PROPANOL |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO810810L NO810810L (en) | 1978-03-02 |
| NO147301B true NO147301B (en) | 1982-12-06 |
| NO147301C NO147301C (en) | 1983-03-16 |
Family
ID=8510232
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO771897A NO144958C (en) | 1976-09-01 | 1977-05-31 | PROCEDURE FOR PREPARING 1-ISOPROPYLAMINE-3- (P- (2-METOXYETHYL) PHENOXY) -2-PROPANOL |
| NO810810A NO147301C (en) | 1976-09-01 | 1981-03-10 | INTERMEDIATE IN THE PREPARATION OF 1-ISOPROPYLAMINE-3- (P-2 (2-METOXYETHYL) PHENOXY) -2-PROPANOL |
| NO810811A NO146427C (en) | 1976-09-01 | 1981-03-10 | INTERMEDIATE IN THE PREPARATION OF 1-ISOPROPYLAMINE-3- (P- (2-METOXYETHYL) PHENOXY) -2-PROPANOL |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO771897A NO144958C (en) | 1976-09-01 | 1977-05-31 | PROCEDURE FOR PREPARING 1-ISOPROPYLAMINE-3- (P- (2-METOXYETHYL) PHENOXY) -2-PROPANOL |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO810811A NO146427C (en) | 1976-09-01 | 1981-03-10 | INTERMEDIATE IN THE PREPARATION OF 1-ISOPROPYLAMINE-3- (P- (2-METOXYETHYL) PHENOXY) -2-PROPANOL |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPS606350B2 (en) |
| DK (1) | DK213877A (en) |
| FI (1) | FI55649C (en) |
| NO (3) | NO144958C (en) |
| PL (1) | PL109138B1 (en) |
| SE (3) | SE443137B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL212286B1 (en) | 2010-06-20 | 2012-09-28 | Inst Immunologii I Terapii Doswiadczalnej Pan | Method for the preparation of bacteriophages |
-
1976
- 1976-09-01 FI FI762507A patent/FI55649C/en not_active IP Right Cessation
-
1977
- 1977-02-04 PL PL1977195815A patent/PL109138B1/en unknown
- 1977-05-03 SE SE7705120A patent/SE443137B/en not_active IP Right Cessation
- 1977-05-17 DK DK213877A patent/DK213877A/en not_active Application Discontinuation
- 1977-05-31 NO NO771897A patent/NO144958C/en unknown
- 1977-06-15 JP JP52071587A patent/JPS606350B2/en not_active Expired
-
1981
- 1981-03-10 NO NO810810A patent/NO147301C/en unknown
- 1981-03-10 NO NO810811A patent/NO146427C/en unknown
-
1985
- 1985-10-25 SE SE8505035A patent/SE462489B/en not_active IP Right Cessation
- 1985-10-25 SE SE8505036A patent/SE462490B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE8505035L (en) | 1985-10-25 |
| NO771897L (en) | 1978-03-02 |
| SE8505035D0 (en) | 1985-10-25 |
| NO810810L (en) | 1978-03-02 |
| NO147301C (en) | 1983-03-16 |
| FI762507A (en) | 1978-03-02 |
| JPS53105440A (en) | 1978-09-13 |
| PL195815A1 (en) | 1978-03-13 |
| SE443137B (en) | 1986-02-17 |
| JPS606350B2 (en) | 1985-02-18 |
| FI55649C (en) | 1979-09-10 |
| NO144958C (en) | 1981-12-16 |
| SE7705120L (en) | 1978-03-02 |
| SE8505036L (en) | 1985-10-25 |
| SE462489B (en) | 1990-07-02 |
| NO146427B (en) | 1982-06-21 |
| NO146427C (en) | 1982-09-29 |
| SE462490B (en) | 1990-07-02 |
| SE8505036D0 (en) | 1985-10-25 |
| NO810811L (en) | 1978-03-02 |
| PL109138B1 (en) | 1980-05-31 |
| FI55649B (en) | 1979-05-31 |
| NO144958B (en) | 1981-09-07 |
| DK213877A (en) | 1978-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO119899B (en) | ||
| CA1066710A (en) | 7-methoxy-6-thiatetracyclines and their preparation | |
| DD229126A5 (en) | PROCESS FOR THE PREPARATION OF TETRONIC ACID | |
| NO147301B (en) | INTERMEDIATE IN THE PREPARATION OF 1-ISOPROPYLAMINE-3- (P-2 (2-METOXYETHYL) PHENOXY) -2-PROPANOL | |
| US2877225A (en) | Preparation of normal-alkyl reserpates and alkyl deserpidates | |
| CN111807975A (en) | Preparation method of hydrochloric acid dopol butylamine intermediate compound | |
| US4041079A (en) | Bicyclic compounds | |
| US3162639A (en) | G-desoxy-ix-hydroxy-dihydromorphine | |
| NO115758B (en) | ||
| US2936312A (en) | 3-oxygenated 6, 17alpha-dimethylandrostan-17beta-ols | |
| US3017427A (en) | 4-amino-2-sulfamylbenzoic acid esters | |
| NO144344B (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE N-ARYLSULPHONYL N`- (3-AZABICYCLOALKYL) | |
| Marekov et al. | The structure of gentioflavine, a new alkaloid of some Gentiana species | |
| FERRIS et al. | α-Oximinoketones. V. The Synthesis of 5-Cyano-2-oximinovaleric Acid and DL-Lysine from 2, 6-Dioximinocyclohexanone1 | |
| Bonner et al. | Amide derivatives of D-glucosamine | |
| CN101723879B (en) | Method for synthesizing (R)-3-ethyl piperidine hydrochloride | |
| SU505366A3 (en) | The method of obtaining - / heteroarylmethyldeoxy-normorphins or norcodeins | |
| DE1793611C3 (en) | ||
| US1951302A (en) | Levo-compounds of the 1-hydroxyphenyl-2-aminopropan-1-ol series and process of preparing them | |
| DE1470020A1 (en) | Alpha-hydrazino-indolyl- (3) -carboxylic acid derivatives and process for their preparation | |
| Kinoshita et al. | Studies on Antibiotics and Related Substances. XXIX. Syntheses of 2-Acetamido-5-oxo-6-heptenoic Acid and 2-Acetamido-4-oxo-5-hexenoic Acid | |
| US2970159A (en) | Hydrazine derivatives | |
| SE411044B (en) | METHOD OF PREPARING PIPERONYL-1 (PYRIMIDINYL-2) -4-PIPERAZINE | |
| US3166560A (en) | G-vlkylmorpiiinan derivatives | |
| US3725393A (en) | 3-n-alkyl-amino-cardenolides and process for their manufacture |